MCK · McKesson Corporation
$1000.77
-1.14% last session
End-of-day data · close of 2026-10-23
Market cap
$117B
Enterprise value
$126B
Trailing P/E
26.8
Forward P/E
19.8
Dividend yield
0.0%
Beta
0.30
Avg volume
1M
Employees
42K
Daily Change %
-1.14%
5 Days Change
0.75%
10 Days Change
5.25%
30 Days Change
14.97%
60 Days Change
15.98%
Month to Day Change
12.63%
Year to Day Change
23.78%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MCK
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-20
Latest call per bank · past 12 months
UBS
Buy$1,200
+19.9% vs priceRBC Capital
Sector Perform$845
-15.6% vs priceBarclays
Overweight$1,000
-0.1% vs priceWells Fargo
Equal-Weight$933
-6.8% vs priceCitigroup
Buy$1,000
-0.1% vs priceJP Morgan
Overweight$1,015
+1.4% vs priceBank of America
Buy$1,000
-0.1% vs priceMorgan Stanley
Overweight$916
-8.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | Mizuho | Maintains | Neutral | $905 → $1,020 |
| 2026-10-16 | UBS | Maintains | Buy | $1,080 → $1,200 |
| 2026-10-07 | Leerink Partners | Maintains | Outperform | $1,030 → $1,070 |
| 2026-09-14 | RBC Capital | Reiterates | Sector Perform | $845 |
| 2026-08-19 | Barclays | Maintains | Overweight | $925 → $1,000 |
| 2026-08-19 | RBC Capital | Initiates | Sector Perform | $0.00 → $845 |
| 2026-08-11 | Wells Fargo | Maintains | Equal-Weight | $812 → $933 |
| 2026-08-06 | TD Cowen | Maintains | Buy | $989 → $1,006 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 10.0% above the 50-day MA ($909.86).
- bullish: Price vs 200-day MA: Trading 16.7% above the 200-day MA ($857.40).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+5.57) — short-term momentum is improving.
- bullish: 52-week range: Price is within 5% of the 52-week high ($1,030.12).
MCK Price Chart
Loading chart for MCK…
Fundamentals
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
More in Medical Distribution
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.